T-PNU

N/A

Report date: 2025/01/26 17:07:22

Base Information

Drug NameT-PNU
Drug Alias Nameanthracycline-based antibody drug conjugates (NBE therapeutics/University Hospital Basel)T-PNU
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulatorsTumor necrosis factor receptor superfamily member 8 modulators
TargetsTumor necrosis factor receptor superfamily member 8Receptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNbe-Therapeutics Ag
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of BaselNbe-Therapeutics Ag
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A